Comparison of pregnancy rates in antagonist cycles after luteal support with GnRH-agonist versus progesterone prospective randomized study

被引：0
|
作者：
Buhbut, E. [1 ]
Ben-Ami, I. [1 ]
Nabulsi, R. [1 ]
Avigdor, G. [1 ]
机构：
[1] Sharre Zedek Mad Ctr, IVF Unit, Jerusalem, Israel
来源：
HUMAN REPRODUCTION | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
O-132
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Efficacy of daily GnRH agonist for luteal phase support following GnRH agonist triggered ICSI cycles versus conventional strategy: A Randomized controlled trial
    Salehpour, Saghar
    Nazari, Leila
    Hosseini, Sedighe
    Azizi, Elham
    Borumandnia, Nasrin
    Hashemi, Teibeh
    JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA, 2021, 25 (03): : 368 - 372
  • [32] Medroxyprogesterone acetate versus ganirelix in oocyte donation cycles stimulated using GnRH antagonist protocol triggered with GnRH-agonist: a randomized controlled trial (RCT)
    Begueria, R.
    Garcia, D.
    Vassena, R.
    Rodriguez, A.
    HUMAN REPRODUCTION, 2018, 33 : 108 - 108
  • [33] Biochemical pregnancy rate in ICSI cycles: GNrH agonist versus antagonist.
    Karatekeli, E
    Ozornek, H
    Jamal, H
    Ergin, E
    FERTILITY AND STERILITY, 2005, 84 : S306 - S306
  • [34] Cumulative live birth rates after IVF-ICSI cycles in women with endometriosis-associated infertility: prolonged GnRH-agonist versus GnRH-antagonist protocols
    Wei, H.
    Chen, Y.
    Li, X.
    Lin, Y.
    Li, R.
    Ma, C.
    HUMAN REPRODUCTION, 2020, 35 : I260 - I261
  • [35] A prospective randomised study comparing a GnRH-antagonist versus a GnRH-agonist short protocol for ovarian stimulation in patients referred for IVF
    Gordts, S.
    Van Turnhout, C.
    Campo, R.
    Puttemans, P.
    Valkenburg, M.
    Gordts, S.
    FACTS VIEWS AND VISION IN OBGYN, 2012, 4 (02): : 82 - 87
  • [36] A PROSPECTIVE RANDOMISED STUDY COMPARING A GNRH-ANTAGONIST VERSUS A GNRH-AGONIST SHORT PROTOCOL FOR OVARIAN STIMULATION IN PATIENTS REFERRED FOR IVF
    Gordts, S.
    Puttemans, P.
    Campo, R.
    Valkenburg, M.
    Gordts, S.
    FERTILITY AND STERILITY, 2011, 96 (03) : S176 - S176
  • [37] Reply: GnRH agonist (buserelin) or hCG for ovulation induction in gnRH antagonist IVF/ICSI cycles: a prospective randomized study
    Humaidan, P
    HUMAN REPRODUCTION, 2005, 20 (11) : 3260 - 3260
  • [38] GnRH agonist administration in the luteal phase does not increase clinical pregnancy or implantation rates following ICSI-ET in GnRH agonist or antagonist treated ovarian stimulation cycles
    Ata, B.
    Yakin, K.
    Balaban, B.
    Urman, B.
    FERTILITY AND STERILITY, 2007, 88 : S163 - S163
  • [39] GNRH-AGONIST TRIGGER IN 'FREEZE-ALL' CYCLES: IMPROVES PREGNANCY RATES AND PATIENT SAFETY.
    Davenport, Marcus J.
    Healey, Martin
    MacLachlan, Vivien B.
    Talmor, Alon J.
    Vollenhoven, Beverley J.
    FERTILITY AND STERILITY, 2019, 112 (03) : E206 - E206
  • [40] Increased pregnancy rates following luteal GnRH agonist addition in natural thawed cleavage-stage embryo transfer cycles: a prospective, randomized, placebo-controlled study
    Ben-Ami, I.
    Gidoni, Y. S.
    Raziel, A.
    Barkat, Y.
    Strassburger, D.
    Bern, O.
    Komarovsky, D.
    Kasterstein, E.
    Maslansky, B.
    Hadari, D.
    Ron-El, R.
    HUMAN REPRODUCTION, 2015, 30 : 71 - 71
12345